Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53–MDM2 Protein–Protein Interaction
- 19 October 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (22) , 9630-9642
Abstract
The p53–MDM2 interaction has been proved to be a valuable target to develop effective antitumor agents. Novel p53–MDM2 inhibitors bearing pyrrolidone scaffolds were successfully identified by structure-based design. The nanomolar inhibitor 5 possessed good p53–MDM2 inhibitory activity (Ki = 780 nM) due to its hydrophobic and hydrogen bonding interactions with MDM2. Further hit optimization led to the discovery of a number of highly potent pyrrolidone derivatives with improved p53–MDM2 inhibitory activity and in vitro antiproliferative potency. Compounds 41 (Ki = 260.0 nM) and 60a (Ki = 150.0 nM) showed good and selective activity against tumor cells with deleted p53. In addition, these two compounds also effectively inhibited the tumor growth in the A549 xenograft model. Interestingly, compound 41 was proved to be a potent MDM2/MDMX dual inhibitor. The novel pyrrolidone p53–MDM2 inhibitors represent promising lead structures for the development of novel antitumor agents.Keywords
This publication has 48 references indexed in Scilit:
- Inhibiting the p53–MDM2 interaction: an important target for cancer therapyNature Reviews Cancer, 2003
- Protein–protein interfaces: mimics and inhibitorsCurrent Opinion in Chemical Biology, 2001
- Surfing the p53 networkNature, 2000
- Antagonists of protein–protein interactionsChemistry & Biology, 2000
- p53 and Human Cancer: The First Ten Thousand Mutations1999
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53?BioEssays, 1993
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992